{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:59:38Z","timestamp":1777532378311,"version":"3.51.4"},"reference-count":41,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1139953"],"award-info":[{"award-number":["1139953"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Chron Respir Dis"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Fibrotic interstitial lung disease (fILD) is characterized by scarring of the lungs, decline in lung function and compromised exercise capacity. People with fILD participate in less daily physical activity compared to healthy controls, however, the relative importance of physical activity components (volume, intensity, duration) is unknown. This study aimed to examine the relationship between the components of physical activity and established disease severity and impact measures in fILD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Participant data were from baseline assessment of a randomized controlled trial recruiting people with fILD and exertional desaturation during exercise testing on room air. Physical activity components including volume (steps per day), intensity (light, moderate and vigorous) and duration (time spent in different physical activity intensities) were objectively assessed for 7\u00a0days using two physical activity monitors. Associations of these components with lung function (FVC, FEV\n                      <jats:sub>1<\/jats:sub>\n                      , TLCO), functional exercise capacity (6-min walk distance, 6MWD) and dyspnea (Dyspnea-12 questionnaire) were investigated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      106 participants with mild to severe fILD were included. Physical activity volume was not associated with 6MWD (r = 0.027,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.78) and weakly associated with lung function (FVC r = 0.33,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001; FEV\n                      <jats:sub>1<\/jats:sub>\n                      r = 0.34,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.001). Physical activity intensity and duration were weakly associated with 6MWD (light r = 0.22\n                      <jats:italic>p<\/jats:italic>\n                      = 0.02; moderate r = 0.42,\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001; vigorous r = 0.33,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.01). Time spent in vigorous physical activity was weakly associated with lung function (FVC r = 0.19,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.05; FEV\n                      <jats:sub>1<\/jats:sub>\n                      r = 0.18,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.006). Dyspnea scores were not associated with any physical activity variables. Relationships remained consistent after adjusting for age, gender and disease severity, with the exception of vigorous physical activity which was no longer associated with lung function or 6MWD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In people with fILD, the physical activity components of volume, intensity and duration were associated with different measures of disease severity and impact. This highlights the importance of considering specific physical activity components when evaluating and promoting physical activity in this group.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/14799731251358584","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T23:09:47Z","timestamp":1754435387000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["What are the important components of physical activity for people with fibrotic interstitial lung disease?"],"prefix":"10.1177","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8818-2958","authenticated-orcid":false,"given":"Mariana","family":"Hoffman","sequence":"first","affiliation":[{"name":"Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, VIC, Australia"},{"name":"Institute of Breathing and Sleep, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christie R.","family":"Mellerick","sequence":"additional","affiliation":[{"name":"Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, VIC, Australia"},{"name":"Institute of Breathing and Sleep, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela T.","family":"Burge","sequence":"additional","affiliation":[{"name":"Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, VIC, Australia"},{"name":"Institute of Breathing and Sleep, Melbourne, VIC, Australia"},{"name":"Physiotherapy, Alfred Health, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E.","family":"Holland","sequence":"additional","affiliation":[{"name":"Respiratory Research@Alfred, School of Translational Medicine, Monash University, Melbourne, VIC, Australia"},{"name":"Institute of Breathing and Sleep, Melbourne, VIC, Australia"},{"name":"Physiotherapy, Alfred Health, Melbourne, VIC, Australia"},{"name":"Respiratory Medicine, Alfred Health, Melbourne, VIC, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2020-102955"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5868-8-80"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.13-0806"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000446607"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2015-095947"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202105-1193ST"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/08964289.1994.9934621"},{"issue":"3","key":"e_1_3_3_9_2","doi-asserted-by":"crossref","first-page":"825","DOI":"10.3390\/s24030825","article-title":"Current knowledge about ActiGraph GT9X link activity monitor accuracy and validity in measuring steps and energy expenditure: a systematic review","volume":"24","author":"Suau Q","year":"2024","unstructured":"Suau Q, Bianchini E, Bellier A, et al. Current knowledge about ActiGraph GT9X link activity monitor accuracy and validity in measuring steps and energy expenditure: a systematic review. Sensors (Basel) 2024; 24(3): 825.","journal-title":"Sensors (Basel)"},{"issue":"9","key":"e_1_3_3_10_2","doi-asserted-by":"crossref","first-page":"e0161224","DOI":"10.1371\/journal.pone.0161224","article-title":"Validity and reliability of fitbit flex for step count, moderate to vigorous physical activity and activity energy expenditure","volume":"11","author":"Sushames A","year":"2016","unstructured":"Sushames A, Edwards A, Thompson F, et al. Validity and reliability of fitbit flex for step count, moderate to vigorous physical activity and activity energy expenditure. PLoS One 2016; 11(9): e0161224.","journal-title":"PLoS One"},{"issue":"1","key":"e_1_3_3_11_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/epirev\/mxab004","article-title":"Assessment of physical activity in adults using wrist accelerometers","volume":"43","author":"Liu F","year":"2022","unstructured":"Liu F, Wanigatunga AA, Schrack JA. Assessment of physical activity in adults using wrist accelerometers. Epidemiol Rev 2022; 43(1): 65\u201393.","journal-title":"Epidemiol Rev"},{"issue":"10","key":"e_1_3_3_12_2","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1164\/rccm.201201-0006PP","article-title":"Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials","volume":"185","author":"Raghu G","year":"2012","unstructured":"Raghu G, Collard HR, Anstrom KJ, et al. Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med 2012; 185(10): 1044\u20131048.","journal-title":"Am J Respir Crit Care Med"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2014-093546"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-040798"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1249\/01.mss.0000185657.86065.98"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.3109\/09638288.2011.641666"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1682\/JRRD.2014.11.0282"},{"issue":"3","key":"e_1_3_3_19_2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.chest.2023.08.024","article-title":"Exertional desaturation during the 6-minute walk test vs daily life in people with fibrotic interstitial lung disease","volume":"165","author":"Hoffman M","year":"2023","unstructured":"Hoffman M, Burge AT, Wong N, et al. Exertional desaturation during the 6-minute walk test vs daily life in people with fibrotic interstitial lung disease. Chest 2023; 165(3): 632\u2013635.","journal-title":"Chest"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060400"},{"issue":"5","key":"e_1_3_3_21_2","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1682\/JRRD.2009.07.0091","article-title":"Use of pedometer and Internet-mediated walking program in patients with chronic obstructive pulmonary disease","volume":"47","author":"Moy ML","year":"2010","unstructured":"Moy ML, Janney AW, Nguyen HQ, et al. Use of pedometer and Internet-mediated walking program in patients with chronic obstructive pulmonary disease. J Rehabil Res Dev 2010; 47(5): 485\u2013496.","journal-title":"J Rehabil Res Dev"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e3182399e5b"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0b013e31820513be"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.5.9710086"},{"key":"e_1_3_3_25_2","doi-asserted-by":"crossref","first-page":"579278","DOI":"10.3389\/fspor.2020.579278","article-title":"Physical activity intensity cut-points for wrist-worn GENEActiv in older adults","volume":"2","author":"Fraysse F","year":"2020","unstructured":"Fraysse F, Post D, Eston R, et al. Physical activity intensity cut-points for wrist-worn GENEActiv in older adults. Front Sports Act Living 2020; 2: 579278.","journal-title":"Front Sports Act Living"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00150314"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0693"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.4324\/9780203771587"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjem.2018.08.001"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjsports-2014-094306"},{"key":"e_1_3_3_32_2","doi-asserted-by":"crossref","first-page":"101142","DOI":"10.1016\/j.pmedr.2020.101142","article-title":"Calibration and validation of accelerometry using cut-points to assess physical activity in paediatric clinical groups: a systematic review","volume":"19","author":"Bianchim MS","year":"2020","unstructured":"Bianchim MS, McNarry MA, Larun L, et al. Calibration and validation of accelerometry using cut-points to assess physical activity in paediatric clinical groups: a systematic review. Prev Med Rep 2020; 19: 101142.","journal-title":"Prev Med Rep"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00024608"},{"key":"e_1_3_3_34_2","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2147\/COPD.S183029","article-title":"24-hour accelerometry in COPD: exploring physical activity, sedentary behavior, sleep and clinical characteristics","volume":"14","author":"Orme MW","year":"2019","unstructured":"Orme MW, Steiner MC, Morgan MD, et al. 24-hour accelerometry in COPD: exploring physical activity, sedentary behavior, sleep and clinical characteristics. Int J Chron Obstruct Pulmon Dis 2019; 14: 419\u2013430.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"e_1_3_3_35_2","first-page":"00132","article-title":"The role of neighbourhood-level sociodemographic and socioeconomic characteristics on the physical activity of people with chronic obstructive pulmonary disease","author":"V\u00e1squez-Andrade R","year":"2025","unstructured":"V\u00e1squez-Andrade R, Delgado-Ortiz L, Arbillaga-Etxarri A, et al. The role of neighbourhood-level sociodemographic and socioeconomic characteristics on the physical activity of people with chronic obstructive pulmonary disease. ERJ Open Research 2025; 00132\u201302025.","journal-title":"ERJ Open Research"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2023.107424"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0277973"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40248-018-0158-z"},{"issue":"4","key":"e_1_3_3_39_2","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.resinv.2019.03.009","article-title":"Four-meter gait speed predicts daily physical activity in patients with chronic respiratory diseases","volume":"57","author":"Yoshida C","year":"2019","unstructured":"Yoshida C, Ichiyasu H, Ideguchi H, et al. Four-meter gait speed predicts daily physical activity in patients with chronic respiratory diseases. Respir Investig 2019; 57(4): 368\u2013375.","journal-title":"Respir Investig"},{"issue":"1","key":"e_1_3_3_40_2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jesf.2014.11.002","article-title":"Validity of the SenseWear armband step count measure during controlled and free-living conditions","volume":"13","author":"Lee JA","year":"2015","unstructured":"Lee JA, Laurson KR. Validity of the SenseWear armband step count measure during controlled and free-living conditions. J Exerc Sci Fit 2015; 13(1): 16\u201323.","journal-title":"J Exerc Sci Fit"},{"key":"e_1_3_3_41_2","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1479-5868-9-84","article-title":"Validity of activity monitors in health and chronic disease: a systematic review","volume":"9","author":"Van Remoortel H","year":"2012","unstructured":"Van Remoortel H, Giavedoni S, Raste Y, et al. Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Activ 2012; 9: 84.","journal-title":"Int J Behav Nutr Phys Activ"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1177\/2333721418781126"}],"container-title":["Chronic Respiratory Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14799731251358584","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/14799731251358584","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/14799731251358584","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:48:21Z","timestamp":1777394901000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/14799731251358584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":41,"alternative-id":["10.1177\/14799731251358584"],"URL":"https:\/\/doi.org\/10.1177\/14799731251358584","relation":{},"ISSN":["1479-9731","1479-9731"],"issn-type":[{"value":"1479-9731","type":"print"},{"value":"1479-9731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"article-number":"14799731251358584"}}